Zydus Lifesciences Limited ZYDUSLIFE.NS · Stock Open Zydus Lifesciences Limited in new tab
Analyst price targets
Recent rating changes, newest first
Zydus Lifesciences Limited Analysis (ZYDUSLIFE.NS)
Is Zydus Lifesciences Limited a good investment? Zydus Lifesciences Limited (ZYDUSLIFE.NS) is currently trading at 1134.40 INR. Market analysts have a consensus price target of 1206.84 INR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 25.70. This valuation is generally in line with the broader market.
Earnings Schedule: Zydus Lifesciences Limited is expected to release its next earnings report on Nov. 14, 2026. The market consensus estimate for Forward EPS is 49.27.
For income investors, Zydus Lifesciences Limited pays a dividend yield of 0.09%. With a payout ratio of 25%, the dividend appears sustainable.
Investor FAQ
Does Zydus Lifesciences Limited pay a dividend?
Yes, it pays an annual dividend of 1.00 INR (0.09% yield).
What asset class is Zydus Lifesciences Limited?
Zydus Lifesciences Limited is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Nov. 14, 2026. The company currently has a trailing EPS of 44.87.
Company Profile
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Consumer Products, and Medical Technologies. The company offers active pharmaceutical ingredients, human and finished dosage formulations, generics, branded generics, specialty formulations, biosimilars, vaccines, novel therapeutics, medical devices and technologies, consumer wellness, veterinary, and animal health products. It also provides biological products in the areas of oncology, autoimmune disorders, nephrology, inflammation, rheumatology, hepatology, and infectious diseases; and designs and executes clinical trials across new chemical entities (NCEs), biologics, vaccines, and specialty generics. In addition, the company operates seasonal, skin and healthcare, and food and nutrition products under the Glucon D, Complan, Sugar Free, Nycil, Everyuth, Nutralite, and RiteBite Max Protein brands. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is headquartered in Ahmedabad, India. Zydus Lifesciences Limited is a subsidiary of Zydus Family Trust.
| Year | Total Dividends |
|---|---|
| ▸2027 |
1.00 INR
|
| Aug. 16, 2027 (estimated) | 1.0000 |
| ▸2026 |
1.00 INR
|
| Aug. 14, 2026 | 1.0000 |
| ▸2025 |
11.00 INR
|
| Aug. 14, 2025 | 11.0000 |
| ▸2024 |
3.00 INR
|
| Aug. 13, 2024 | 3.0000 |
| ▸2023 |
6.00 INR
|
| Sept. 10, 2023 | 6.0000 |
| ▸2022 |
2.50 INR
|
| Aug. 16, 2022 | 2.5000 |
| ▸2021 |
3.50 INR
|
| Sept. 10, 2021 | 3.5000 |
| ▸2020 |
3.50 INR
|
| March 27, 2020 | 3.5000 |
| ▸2019 |
3.50 INR
|
| Sept. 8, 2019 | 3.5000 |
| ▸2018 |
3.50 INR
|
| Sept. 12, 2018 | 3.5000 |
| ▸2017 |
3.20 INR
|
| April 6, 2017 | 3.2000 |
| ▸2016 |
3.20 INR
|
| March 17, 2016 | 3.2000 |
| ▸2015 |
12.00 INR
|
| July 30, 2015 | 12.0000 |
| ▸2014 |
9.00 INR
|
| July 17, 2014 | 9.0000 |
| ▸2013 |
7.50 INR
|
| June 11, 2013 | 7.5000 |
| ▸2012 |
7.50 INR
|
| July 26, 2012 | 7.5000 |
| ▸2011 |
6.25 INR
|
| July 7, 2011 | 6.2500 |
| ▸2010 |
5.00 INR
|
| July 15, 2010 | 5.0000 |
| ▸2009 |
4.50 INR
|
| July 16, 2009 | 4.5000 |
| ▸2008 |
4.50 INR
|
| July 10, 2008 | 4.5000 |
| ▸2007 |
4.00 INR
|
| July 12, 2007 | 4.0000 |
| ▸2006 |
6.00 INR
|
| July 13, 2006 | 6.0000 |
| ▸2005 |
6.00 INR
|
| July 14, 2005 | 6.0000 |
| ▸2004 |
6.00 INR
|
| July 14, 2004 | 6.0000 |
| ▸2003 |
3.50 INR
|
| Sept. 24, 2003 | 3.5000 |
| ▸2002 |
3.50 INR
|
| Sept. 11, 2002 | 3.5000 |
| ▸2001 |
3.00 INR
|
| June 18, 2001 | 3.0000 |
| ▸2000 |
3.00 INR
|
| April 28, 2000 | 3.0000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Zydus Lifesciences Limited | Aug 14, 2026 | Paid | 1.0 INR |
| Split Date | Split Ratio to 1 |
|---|---|
| Aug. 30, 2006 | 2:1 |
| April 5, 2010 | 1.5 |
| Oct. 6, 2015 | 5:1 |
Community Discussion